Navigation Links
Fixed Core Straight Safety Wire Guides - Standard (stainless steel SlipCoat®)

ProductsFixed Core Straight Safety Wire Guides - Standard (stainless steel SlipCoat®)
Company Cook Urological
Item Fixed Core Straight Safety Wire Guides - Standard (stainless steel SlipCoat®)
Features 
  • Supplied sterile in peel-open packages.
    • Description Supplied sterile in peel-open packages. Intended for one-time use.
    Info Cook Urological
    Customer Service: (800) 457-4448
    Web site: http://www.cookurological.com/

    Related medicine products :

    1. Straight Fixed Core Wire Guides
    2. Small Anatomy Fixed Curve Catheters
    3. Inquiry Fixed Curve Diagnostic Catheters
    4. Webster Small Anatomy Fixed Curve Catheters
    5. Webster Supra CS Decapolar (Coronary Sinus Fixed Curve Catheters)
    6. Explorer ST Fixed Curve Diag. Catheters
    7. Webster Santoro 20 Pole Fixed Curve Catheter
    8. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
    9. Webster Luminal Decapolar (Coronary Sinus Fixed Curve Catheters)
    10. I-Stat Low Temperature Cautery, Fixed
    11. Accu-Temp Fixed, 1205C (2200F), 1/2" shaft with fine tip
    Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Mediterranean diet associated with reduced risk of depression 10311 1Mediterranean diet associated with reduced risk of depression 10311 2Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 1Common herbicides and fibrates block nutrient sensing receptor found in gut and pancreas 10307 2Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 1Miscarriage Treatment Wont Harm Future Fertility 3A Study 59205 2